Last reviewed · How we verify

MMR vaccine (Priorix) — Competitive Intelligence Brief

MMR vaccine (Priorix) (MMR vaccine (Priorix)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology / Infectious Disease.

marketed Live attenuated vaccine Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

MMR vaccine (Priorix) (MMR vaccine (Priorix)) — GlaxoSmithKline. Priorix is a live attenuated vaccine that stimulates the immune system to produce antibodies and cellular immunity against measles, mumps, and rubella viruses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
MMR vaccine (Priorix) TARGET MMR vaccine (Priorix) GlaxoSmithKline marketed Live attenuated vaccine
Bacillus Calmette-Guerin (BCG) Bacillus Calmette-Guerin (BCG) Massachusetts General Hospital marketed Live attenuated vaccine / Immunotherapy
live attenuated Japanese encephalitis vaccine live attenuated Japanese encephalitis vaccine Chinese Academy of Medical Sciences marketed Live attenuated vaccine
Rotarix (RV1) Rotarix (RV1) Telethon Kids Institute marketed Live attenuated vaccine Rotavirus VP4 and VP7 surface proteins
Attenuated Hepatitis A Vaccine, H2 Strain Attenuated Hepatitis A Vaccine, H2 Strain Jiangsu Province Centers for Disease Control and Prevention marketed Live attenuated vaccine Hepatitis A virus
Bacille Calmette-Guérin (BCG) Bacille Calmette-Guérin (BCG) TASK Applied Science marketed Live attenuated vaccine / Immunotherapy Pattern recognition receptors (TLR2, TLR4, NOD2); non-specific immune activation
Measles, mumps, rubella vaccine Measles, mumps, rubella vaccine PATH marketed Live attenuated vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

  1. GlaxoSmithKline · 19 drugs in this class
  2. Merck Sharp & Dohme LLC · 11 drugs in this class
  3. Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
  4. PATH · 5 drugs in this class
  5. Sanofi · 5 drugs in this class
  6. Bandim Health Project · 5 drugs in this class
  7. Centers for Disease Control and Prevention · 3 drugs in this class
  8. International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
  9. Beijing Center for Disease Control and Prevention · 2 drugs in this class
  10. Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). MMR vaccine (Priorix) — Competitive Intelligence Brief. https://druglandscape.com/ci/mmr-vaccine-priorix. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: